Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells

Go back to Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells
(NASDAQ: AUTL) Delayed: 1.86 --0 (-0%)
Previous Close $1.86    52 Week High $ 
Open $1.82    52 Week Low $ 
Day High $1.89    P/E N/A 
Day Low $1.79    EPS $ 
Volume 1,399,626